| 11964989 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more |
2024-04-23 |
| 11932633 |
KRas G12C inhibitors |
Matthew Arnold Marx, Matthew Lee, James F. Blake, Mark Joseph Chicarelli, Jay Bradford Fell +5 more |
2024-03-19 |
| 11453683 |
KRas G12D inhibitors |
Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson +21 more |
2022-09-27 |
| 11267812 |
KRAS G12C inhibitors |
John P. Fischer, Jay Bradford Fell, James F. Blake, Ronald Jay Hinklin, Macedonio J. Mejia +10 more |
2022-03-08 |
| 10689377 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Adam Cook +7 more |
2020-06-23 |
| 10633381 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2020-04-28 |
| 10125134 |
KRas G12C inhibitors |
James F. Blake, Laurence E. Burgess, Mark Joseph Chicarelli, James Gail Christensen, Jay Bradford Fell +11 more |
2018-11-13 |
| 8680114 |
AKT protein kinase inhibitors |
Ian S. Mitchell, Keith L. Spencer, Peter J. Stengel, Yongxin Han, Nicholas C. Kallan +10 more |
2014-03-25 |
| 8518983 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi +5 more |
2013-08-27 |
| 8017641 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi +5 more |
2011-09-13 |
| 7799782 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Gronenberg, James P. Rizzi +5 more |
2010-09-21 |
| 7521447 |
P38 inhibitors and methods of use thereof |
Mark Munson, David A. Mareska, Youngboo Kim, Robert D. Groneberg, James P. Rizzi +5 more |
2009-04-21 |
| 7439249 |
Inhibitors of phosphatases |
Jeffrey O. Saunders, Gregory F. Miknis, Alexandre Joseph Buckmelter, Kevin W. Hunt, James F. Blake +1 more |
2008-10-21 |
| 7144988 |
Method of structure-based drug design to create or improve modulators of IL-1 activity which bind to the interleukin-1 type 1 receptor |
Barbara J. Brandhuber |
2006-12-05 |
